Elucidate Bio

Elucidate Bio is a private, early-stage biotech services company founded in 2020 and based in San Diego. It operates at the intersection of spatial biology, multi-omics, and artificial intelligence, offering a contract research service to pharmaceutical and biotech companies. The company's core value proposition is using its proprietary methods for same-tissue, multi-modal imaging and AI-driven analysis to uncover predictive biomarkers of patient response, thereby de-risking and accelerating drug development programs. It appears to be pre-revenue or in early revenue, focusing on building its client base and scientific credibility through case studies and partnerships.

Integrated spatial multi-omics platform enabling same-tissue, single-cell resolution imaging of DNA, RNA, and protein, combined with advanced AI/ML for biomarker discovery and predictive insights.

Competes against large, diversified contract research organizations (CROs), specialized genomics service labs, and the internal spatial biology teams of pharmaceutical clients. Differentiation hinges on technical prowess in integrated multi-modal imaging and the application of proprietary AI for insight generation, not just data generation.